Metraipolis › archive › dc_dc7cbef2b408

Ocular gene therapy as a sustained drug delivery system: pharmacokinetic and genokinetic perspectives — Europe PMC PMID:41532047

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41532047
DOI: 10.25122/jml-2025-0180
License (as archived): solo-consultazione
Archived: 2026-11-08T21:33:19.246Z
SHA-256 of the archived text: c4f2fa501e87a32b793fc10345623590c95d5dd29baa38d6976c3573b5fab4d3
Stable URL of this page: https://metraipolis.com/documento/dc_dc7cbef2b408

How to cite

Ocular gene therapy as a sustained drug delivery system: pharmacokinetic and genokinetic perspectives — Europe PMC PMID:41532047 — Europe PMC (en), https://europepmc.org/article/MED/41532047 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dc7cbef2b408 (Metraipolis archive dc_dc7cbef2b408, sha256 c4f2fa501e87a32b793fc10345623590c95d5dd29baa38d6976c3573b5fab4d3)

BibTeX

@misc{dcdc7cbef2b408,
  title = {Ocular gene therapy as a sustained drug delivery system: pharmacokinetic and genokinetic perspectives — Europe PMC PMID:41532047},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41532047},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dc7cbef2b408; sha256 c4f2fa501e87a32b793fc10345623590c95d5dd29baa38d6976c3573b5fab4d3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41532047. Agents can read the archived copy with the MCP tool read_document.